Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H12N2O2S |
Molecular Weight | 272.322 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)C1=CC=C(C=C1)C2=CN3C=CC=CC3=N2
InChI
InChIKey=VSLIUWLPFRVCDL-UHFFFAOYSA-N
InChI=1S/C14H12N2O2S/c1-19(17,18)12-7-5-11(6-8-12)13-10-16-9-3-2-4-14(16)15-13/h2-10H,1H3
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/947202
Curator's Comment: Zolimidine is brain penetrant in animals. No human data available.
Originator
Sources: https://www.google.ch/patents/US3318880
Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/zolimidine.html
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
||
|
WHO-VATC |
QA02BX10
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
||
|
WHO-ATC |
A02BX10
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000078815
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
3661
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
DTXSID9057630
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
C073260
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
YCF001N8QB
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
1222-57-7
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
SUB00179MIG
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105534
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
ZOLIMIDINE
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
DB13593
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
14652
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
3089
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
214-947-4
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | |||
|
m11659
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY | Merck Index | ||
|
C66705
Created by
admin on Sat Dec 16 16:33:14 GMT 2023 , Edited by admin on Sat Dec 16 16:33:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY